Marsico Capital Management LLC Adaptive Biotechnologies Corp Transaction History

Marsico Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $3.44 Million - $4.76 Million	-106,723 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $621,683 - $1.13 Million	16,685 Added 18.53%	106,723 $4.3 Million
Q3 2020 Nov 13, 2020	BUY	$35.79 - $48.81 $3.22 Million - $4.39 Million	90,038 New	90,038 $4.38 Million

184

152M

8.4K

56K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $759M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Marsico Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Marsico Capital Management LLC with notifications on news.